If unable to avoid coadministration of belzutifan with delicate CYP3A4 substrates, look at increasing the delicate CYP3A4 substrate dose in accordance with its prescribing details. Monitor carefully (1)lumefantrine will lessen the extent or influence of exemestane by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/watch. For suf